What Parameter Adjustments And Clinical Guidelines Should Aesthetic Practitioners Follow When Treating Melasma, Dyschromia, And Acne Scars With Nonablative Fractional Lasers? Master Safe, Effective Protocols.

For melasma and dyschromia, use conservative, low-thermal-load settings; for acne scars, use deeper, higher-fluence treatment at lower density. Parameters must be adapted to the device, wavelength, indication, scar morphology, and Fitzpatrick skin type. Melasma requires particular caution because excessive heat or inflammation can worsen post-inflammatory hyperpigmentation (PIH) and trigger rebound pigmentation.

The central principle is controlled injury: minimize treatment density and energy when treating pigment, especially in Fitzpatrick IV–VI skin, but deliver sufficient dermal energy and spacing to stimulate collagen remodeling in acne scars. Always combine treatment with photoprotection, appropriate topical therapy, informed consent, and realistic expectations.

Start With the Diagnosis and Risk Profile

Confirm the pigmentary diagnosis

Melasma is a chronic, relapse-prone disorder rather than a simple collection of excess surface pigment. Practitioners should assess hormonal triggers, ultraviolet and visible-light exposure, medications, inflammation, and prior treatment response before selecting a laser protocol.

Dyschromia is a broader category that may include lentigines, post-inflammatory hyperpigmentation, and uneven superficial pigmentation. These conditions do not necessarily respond to the same wavelength, density, or energy used for melasma.

Classify acne scars before treating

Atrophic scars should be categorized as ice-pick, boxcar, or rolling scars. Rolling scars often contain tethered fibrous bands and may respond better when laser resurfacing is combined with subcision.

Hypertrophic or keloid-prone scarring requires particular caution. A nonablative fractional laser should not be treated as a universal solution for every raised scar; diagnosis and scar biology must guide management.

Consider Fitzpatrick skin type

Darker phototypes, particularly Fitzpatrick IV–VI, have a higher risk of PIH after thermal or inflammatory procedures. In these patients, the treatment endpoint should be controlled erythema and gradual improvement—not aggressive visible injury.

A test spot can help evaluate the patient’s inflammatory and pigmentary response before treating a larger area.

Adjusting Parameters for Melasma and Dyschromia

Use low energy and conservative thermal exposure

For melasma, use low pulse energy and conservative fluence. The purpose is to facilitate pigment clearance while limiting inflammation and heat that could stimulate melanogenesis.

A commonly described 1927-nm thulium approach uses approximately 10–20 mJ, with reported coverage ranges of 20%–70% and multiple passes. These figures are device-specific examples, not universal prescriptions; the manufacturer’s energy units, coverage calculations, pulse structure, and treatment endpoint must take precedence.

Reduce density when PIH risk is high

The primary safety adjustment for melasma and darker skin is to reduce the overall thermal burden. This generally means using lower microbeam or microscopic treatment zone density, fewer passes when needed, and conservative energy.

Some superficial dyschromia protocols use low energy with higher density. That approach should not be transferred automatically to melasma or Fitzpatrick IV–VI skin, where lower density may be safer. The correct choice depends on the diagnosis, wavelength, device, and whether the pigment is epidermal or dermal.

Do not chase immediate pigment clearance

Fractional treatment clears pigment through mechanisms that include melanophage disruption, dermal dispersion, and microscopic epidermal necrotic debris (MEND) extrusion. Because only a fraction of the skin is treated in each pass, improvement is progressive rather than instantaneous.

Excessive passes or energy do not necessarily produce faster clearance. They increase inflammation and may worsen the very pigmentation being treated.

Treat laser therapy as an adjunct

Fractional laser treatment is generally better considered an adjunct or alternative when topical therapy is ineffective or poorly tolerated, rather than a stand-alone cure for melasma.

A typical course may involve four to six sessions, but the interval and total number should be determined by the patient’s response and recovery. Long-term control requires daily broad-spectrum sunscreen and, when appropriate, clinician-directed topical therapy such as hydroquinone, retinoids, or tranexamic acid.

Adjusting Parameters for Acne Scars

Use higher fluence with lower spot density

Acne scars require a different strategy from pigmentary disorders. The objective is sufficient deep dermal thermal stimulation to promote collagen remodeling while preserving untreated skin between microcolumns.

Accordingly, acne-scar protocols generally use higher fluence, lower spot density, and sometimes multiple passes compared with melasma protocols. The exact energy depends on wavelength, spot size, pulse duration, device architecture, and the depth and type of scar.

Treat the scar morphology, not only the skin surface

Rolling scars may benefit from subcision before or alongside fractional laser treatment. Subcision releases the tethered fibrous bands, while the laser provides progressive thermal remodeling and collagen reorganization.

Boxcar and ice-pick scars may require a different combination of procedures. A fractional laser can improve texture and scar edges, but it may not fully address very narrow or deep defects without additional scar-specific treatment.

Use the device’s units correctly

Some reported acne-scar protocols use a double-pulse technique at approximately 28–32 J/cm², with sessions spaced roughly two to six weeks apart. These values cannot be transferred between devices without accounting for wavelength, pulse duration, spot size, and fluence convention.

Treat the numerical range as a protocol example rather than a default setting. The practitioner should follow the system’s instructions for use and adjust to the patient’s response and the desired dermal endpoint.

Allow time for collagen remodeling

A practical course often consists of four to six sessions, although some protocols use at least three sessions. Intervals commonly range from two to six weeks, depending on device intensity, tissue recovery, and the treatment plan.

Visible improvement may continue for three to six months after treatment because collagen remodeling and dermal reorganization are delayed biological processes.

Prepare the Patient and Protect the Epidermis

Stabilize pigment before treatment

For patients at significant risk of PIH, clinicians may consider a pre-treatment depigmenting regimen. The supplied protocols describe hydroquinone 4% and tretinoin initiated approximately four to six weeks before treatment, with retinoic acid discontinued about two weeks before the procedure.

This regimen must be individualized and prescribed only when appropriate. Irritant dermatitis from topical agents can itself increase PIH risk, so the skin should be calm and intact before treatment.

Enforce photoprotection

Strict photoprotection is essential before and after treatment. Patients should use broad-spectrum sunscreen, with the supplied guidance recommending SPF greater than 30, and should reduce exposure to ultraviolet and visible light as much as practical.

For melasma, photoprotection is not an optional aftercare measure. It is part of the treatment because ongoing light exposure can undermine pigment clearance and promote recurrence.

Prepare and cool the skin correctly

Remove makeup, creams, and topical residues before firing. Residual products may reflect or absorb energy and contribute to unwanted epidermal heating.

Confirm effective epidermal contact and chilled-air or other cooling systems before treatment. Cooling does not replace conservative parameter selection, but it helps reduce discomfort and excessive surface thermal load.

Monitor Endpoints and Recovery

Use controlled erythema as a guide

The endpoint should be consistent with the device and indication, usually controlled erythema and expected edema rather than excessive burning, prolonged inflammation, blistering, or crusting.

If the patient develops unexpectedly intense pain, marked swelling, blistering, or prolonged erythema, stop and reassess rather than escalating treatment.

Schedule reassessment before repeating treatment

Do not repeat treatment simply because early improvement appears limited. Melasma may need weeks to show pigment change, while acne-scar remodeling continues for months.

At each review, document pigment response, PIH, erythema duration, texture change, and patient adherence to photoprotection. These findings should determine whether to maintain, reduce, or cautiously increase treatment intensity.

Understanding the Trade-offs

More energy is not automatically better

Higher energy may improve dermal coagulation and collagen stimulation in acne scars, but it also increases pain, inflammation, downtime, and PIH risk. This trade-off is especially important in darker phototypes and in patients with a history of abnormal pigmentation.

Higher density can increase inflammation

Treating more microzones per pass may improve coverage for selected superficial dyschromia protocols. However, increasing density also increases the cumulative inflammatory burden, which is undesirable in melasma or PIH-prone skin.

Melasma commonly recurs

Even a strong initial response does not eliminate the underlying tendency toward pigment production. Laser monotherapy is therefore insufficient for durable control in many patients.

Combination treatment requires planning

Subcision, topical depigmenting agents, injectables, or other procedures may improve outcomes in appropriately selected patients. Combining treatments without allowing adequate recovery can increase inflammation and obscure which treatment caused an adverse response.

How to Apply This to Your Project

Use a staged protocol: establish the diagnosis and phototype, stabilize active inflammation, select conservative settings for pigment, and reserve deeper higher-fluence treatment for appropriately classified acne scars.

If your primary focus is melasma: Use low-energy, conservative-density fractional treatment as an adjunct to topical therapy and strict photoprotection, with particular caution in Fitzpatrick IV–VI skin.
If your primary focus is superficial dyschromia: Consider low-energy treatment with density matched to the diagnosis and device, while avoiding assumptions that a superficial pigment protocol is safe for melasma.
If your primary focus is atrophic acne scars: Use higher fluence and lower spot density to achieve controlled dermal remodeling, tailoring passes and depth to the scar morphology.
If your primary focus is rolling scars: Consider subcision with fractional laser resurfacing when tethering is present, because thermal remodeling alone may not release the underlying bands.
If your primary focus is safety: Use a test spot, follow the device-specific instructions for use, protect the epidermis, document endpoints, and delay escalation until the full inflammatory response is known.

The safest effective protocol is the least aggressive treatment that produces the intended biological endpoint and can be repeated consistently.

Summary Table:

Condition	Key Parameters	Safety Considerations
Melasma	Low energy, low density, conservative fluence	High PIH risk, avoid over-treatment, use photoprotection
Dyschromia	Low energy, density matched to diagnosis	Assess epidermal vs dermal pigment, test spot
Acne Scars	Higher fluence, lower density, multiple passes	Morphology-specific (ice-pick, boxcar, rolling), consider subcision
Fitzpatrick IV–VI	Reduce density and energy	Strict photoprotection, pre-treatment depigmenting regimen

Ready to enhance your practice with advanced fractional laser technology? At BELIS, we offer a comprehensive range of FDA-cleared laser systems, including the 1927nm thulium and 1550nm erbium lasers, perfect for treating melasma, dyschromia, and acne scars. Our devices are trusted by leading clinics and premium salons worldwide, backed by OEM/ODM support and global certifications. Contact our team today to schedule a consultation and discover how our solutions can elevate your patient outcomes and profitability. Contact us now to learn more.